PCOS Is Now PMOS: What the Rename Actually Means For You
In May 2026, PCOS was officially renamed polyendocrine metabolic ovarian syndrome (PMOS) after a 14-year international consensus process, because the old name focused on 'ovarian cysts' that usually aren't real cysts at all. Your diagnosis and treatment don't change -- just the label, and that's rolling out slowly.
If you've had PCOS for a while, you might have noticed your doctor -- or a headline, or a fertility app -- suddenly calling it PMOS instead. You didn't miss a memo, and no, it's not a typo. As of May 2026, polycystic ovary syndrome (PCOS) was officially renamed polyendocrine metabolic ovarian syndrome (PMOS). Same condition, same you, new label. Let's get into why anyone bothered.
Why rename a condition that's existed for decades?
Honestly, "polycystic ovary syndrome" was always kind of a bad name. The "cysts" it's named after usually aren't cysts at all -- they're immature ovarian follicles that never quite got the memo to mature and release an egg. You don't even need to have them show up on an ultrasound to be diagnosed. So the name centers a feature that's neither required nor, technically, accurate.
Worse, "ovary syndrome" makes it sound like a fertility-only, reproductive-only problem, when in reality PMOS is a whole-body hormonal and metabolic condition. It's linked to insulin resistance (even in people who aren't overweight), higher long-term risk of type 2 diabetes, cardiovascular disease, and fatty liver disease, on top of the more commonly discussed stuff like irregular periods, acne, excess hair growth, and ovulation problems. A name that only mentions the ovaries buries most of that.
This wasn't a snap decision by one committee, either. The rename came out of a 14-year international consensus process involving dozens of professional and patient organizations and Delphi-method surveys of tens of thousands of patients and clinicians. The final rationale was published by Teede and colleagues in Fertility and Sterility in 2025, and the formal global consensus was announced through The Lancet in May 2026. Surveyed support was strong: roughly 86% of patients and 71% of clinicians backed the change, largely citing stigma, confusion, and fragmented care under the old name.
So what's actually different now?
Practically? Not much, not yet. Your diagnosis is still your diagnosis. The diagnostic criteria haven't changed. Treatment -- whether that's metformin, hormonal birth control, lifestyle changes, ovulation induction, or anything else -- hasn't changed either. Major medical groups like the American Society for Reproductive Medicine have endorsed the new terminology, but the actual rollout across guidelines, insurance codes, and everyday clinical paperwork is expected to take about three years. You'll probably see "PCOS" on your chart and your prescriptions for a while yet.
What is shifting is framing. The new name is meant to nudge clinicians (and patients) to think about the metabolic and endocrine side of the condition as seriously as the reproductive side -- not instead of fertility concerns, but alongside them. If your care up to now has been entirely about your cycle and nothing about your blood sugar, cholesterol, or cardiovascular risk, this might be a good moment to bring that up at your next appointment.
Does the new name change anything about trying to conceive?
Not the underlying biology, no. If irregular or absent ovulation from PMOS is part of why you're not conceiving, the same tools still apply: things like tracking ovulation more precisely, working with a doctor on ovulation induction if needed, and paying attention to the metabolic side, since insulin resistance can itself interfere with ovulation. If you're curious whether a newer medication class has a role here too, there's actual research on that -- see our piece on GLP-1 drugs and fertility, which turns out to be one of the more active research areas tied directly to this condition right now.
One thing worth remembering: this condition affects an estimated 1 in 10 women of reproductive age, and up to 70% of cases are thought to go undiagnosed. If period irregularity, unexplained hair growth or acne, or unexplained ovulation trouble sound familiar and you haven't been evaluated, a rename in the news might be as good a nudge as any to ask your doctor about it -- regardless of which name is on the chart.
References
- Teede, H.J., Gibson-Helm, M., Tay, C.T., et al. (2025). From polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome: A process and rationale for renaming. Fertility and Sterility.
- International PCOS/PMOS consensus panel. (2026). Global consensus on renaming polycystic ovary syndrome. The Lancet.
- American Society for Reproductive Medicine. (2026, May 27). PCOS is now PMOS: Understanding the name change.
- Yale Medicine. (2026, June 23). PCOS is renamed PMOS: What you need to know.
Common questions
Do I need to do anything about my diagnosis now that PCOS is called PMOS?
No. Your existing PCOS diagnosis is still valid, and diagnostic criteria haven't changed. You'll likely keep seeing 'PCOS' on insurance paperwork, prescriptions, and medical records for a while yet, since the rollout is planned to happen gradually over about three years.
Why did they change the name in the first place?
Mainly because 'polycystic ovaries' is misleading -- the 'cysts' seen on ultrasound are actually immature ovarian follicles, not true cysts, and you don't even need them to be diagnosed. The old name also made the condition sound like a purely ovarian or fertility issue, when it's really a broader hormonal and metabolic one.
Does this mean there's new research changing how PMOS is treated?
Not directly -- this was a naming and framing exercise, not a new treatment breakthrough. That said, the renaming process did put a lot of attention on the metabolic side of the condition (insulin resistance, cardiovascular risk), which may nudge more clinicians toward looking at the whole picture instead of just cycles and fertility.